11 results
8-K
EX-3.1
KNTE
Kinnate Biopharma Inc
28 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
, including, without limitation, and for the avoidance of doubt, any auditor, underwriter, expert, control person or other defendant.
Any person
DEF 14A
KNTE
Kinnate Biopharma Inc
30 Apr 21
Definitive proxy
9:13am
committee financial expert, as that term is defined under the SEC rules implementing Section 407 of the Sarbanes-Oxley Act of 2002, and possesses
424B4
KNTE
Kinnate Biopharma Inc
3 Dec 20
Prospectus supplement with pricing info
4:48pm
. Gordon and Dr. Rome. Ms. Epperly is the chair of our audit committee and is an audit committee financial expert, as that term is defined under the SEC
S-1/A
kfzm057csimd7qr68
30 Nov 20
IPO registration (amended)
6:05am
S-1
01848yx 7sy9bqihso
13 Nov 20
IPO registration
5:03pm
DRS/A
o8vq711i
3 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
tp88n
16 Oct 20
Draft registration statement (amended)
12:00am
DRS
adu95zq3
4 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next